Agios shareholders elect four Class II directors, approve say-on-pay, ratify auditor at 2024 annual meeting

AGIOS PHARMACEUTICALS, INC.

Elected Kaye Foster (45.8M for, 5.3M withheld), Maykin Ho (46.7M for, 4.4M withheld), Jeffrey Capello (47.8M for, 3.3M withheld), Catherine Owen (45.6M for, 5.5M withheld) as Class II directors.
Advisory vote on named executive officer compensation approved: 48.0M for, 3.1M against, 13,404 abstaining.
Ratified PricewaterhouseCoopers LLP as independent auditor: 52.3M for, 70,843 against, 2,396 abstaining.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.